| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 61.109 | 74.609 | 85.935 | 119.642 | 175.099 | 272.771 | 322.315 | 315.946 | 377.909 | 484.682 |
| Total Income - EUR | 61.212 | 74.610 | 85.935 | 119.643 | 175.100 | 278.253 | 329.473 | 315.950 | 432.494 | 484.683 |
| Total Expenses - EUR | 30.184 | 43.386 | 47.487 | 70.280 | 107.731 | 140.113 | 152.620 | 142.908 | 222.403 | 261.620 |
| Gross Profit/Loss - EUR | 31.028 | 31.223 | 38.448 | 49.363 | 67.369 | 138.140 | 176.853 | 173.042 | 210.091 | 223.063 |
| Net Profit/Loss - EUR | 29.189 | 30.475 | 36.339 | 48.167 | 65.618 | 135.776 | 173.953 | 170.041 | 206.422 | 196.590 |
| Employees | 3 | 4 | 3 | 4 | 6 | 9 | 7 | 6 | 5 | 7 |
Check the financial reports for the company - Avesta Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 13.449 | 9.152 | 22.228 | 29.509 | 28.378 | 73.476 | 63.192 | 55.327 | 40.419 | 67.881 |
| Current Assets | 28.006 | 56.858 | 52.144 | 81.290 | 136.748 | 277.120 | 367.938 | 336.904 | 205.157 | 183.432 |
| Inventories | 0 | 0 | 0 | 88 | 306 | 797 | 1.002 | 3.703 | 3.582 | 0 |
| Receivables | 26.468 | 55.958 | 47.178 | 63.801 | 118.203 | 207.647 | 344.225 | 320.608 | 193.276 | 147.415 |
| Cash | 1.538 | 901 | 4.966 | 17.401 | 18.238 | 68.675 | 22.711 | 12.592 | 8.299 | 36.018 |
| Shareholders Funds | 247 | 245 | 36.579 | 84.075 | 148.065 | 255.573 | 402.593 | 371.105 | 223.821 | 196.831 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 41.207 | 65.766 | 37.792 | 26.724 | 17.060 | 95.023 | 28.538 | 21.126 | 21.755 | 54.529 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Avesta Medical Srl